Medium chain triglyceride formulation comprising transplatin as the therapeutic agent are prepared as described in Examples A5 and A6 with the exception that the JNK inhibitor is replaced with transplatin
For more information regarding homocysteine and CVD, see the article on folate
In some embodiments, the otic formulation or composition comprises about 18% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
It does not contain electrolytes or other drugs, and it will not treat any condition on its own
The right choice depends on your injury, your goals, and the medical team's assessment
As a result, benzyl alcohol is frequently used in low concentrations in human medicine as an antimicrobial preservative in Bacteriostatic water to inhibit bacterial growth